Characterization of estrogen quinone-derived protein adducts and their identification in human serum albumin derived from breast cancer patients and healthy controls

Toxicology Letters

Volumn 202, Issue 3, 2011, Pages 244-252

  Chen, Dar Ren ^a   Chen, Shou Tung ^a   Wang, Tzu Wen ^b   Tsai, Chen His ^b   Wei, Hz Han ^b   Chen, Guan Jie ^b   Yang, Tsung Chou ^b   Lin, Che ^a   Lin, Po Hsiung ^b  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^b NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

Biomarker; Estrogen; Protein adducts; Quinones

Indexed keywords

17BETA ESTRADIOL 2,3 QUINONE; 2,3,7,8, TETRACHLORODIBENZO 4 DIOXIN; ACETYLCYSTEINE; ALBUMIN; DIOXIN; ESTROGEN; QUINONE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BLOOD DONOR; BREAST CANCER; CELL CULTURE; CONTROLLED STUDY; GAS CHROMATOGRAPHY; HUMAN; HUMAN CELL; IN VITRO STUDY; MASS SPECTROMETRY; PRIORITY JOURNAL;

ACETYLCYSTEINE; ADULT; BENZOQUINONES; BREAST NEOPLASMS; CELL LINE, TUMOR; ESTRADIOL; ESTROGENS; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MIDDLE AGED; SERUM ALBUMIN; YOUNG ADULT;

EID: 79954608059     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2011.02.010     Document Type: Article

References (38)

1. Akanni A., Abul-Hajj Y.J. Estrogen-nucleic acid adducts: dissection of the reaction of 3, 4-estrone quinone and its radical anion and radical cation with deoxynucleosides and DNA. Chem. Res. Toxicol. 1999, 12:1247-1253.
2. Bolton J.L., Thatcher G.R. Potential mechanisms of estrogen quinone carcinogenesis. Chem. Res. Toxicol. 2008, 21:93-101.
3. Bonner M.R., Han D., Nie J., Rogerson P.E., Muti P., Trevisan M., Freudenheim J.L. Breast cancer risk and exposure in early life to polycyclic aromatic hydrocarbons using total suspended particulates as a proxy measure. Cancer Epidemiol. Biomarkers Prev. 2005, 14:53-60.
4. Brody J.G., Moysich K.B., Humblet O., Attfield K.R., Beehler G.P., Rudel R.A. Environmental pollutants and breast cancer: epidemiologic studies. Cancer 2007, 109(12 Suppl.):2667-2711.
5. Butterworth M., Lau S.S., Monks T.J. 17 beta-Estradiol metabolism by hamster hepatic microsomes: comparison of catechol estrogen O-methylation with catechol estrogen oxidation and glutathione conjugation. Chem. Res. Toxicol. 1996, 9:793-799.
6. Cao K., Stack D.E., Ramanathan R., Gross M.L., Rogan E.G., Cavalieri E.L. Synthesis and structure elucidation of estrogen quinones conjugated with cysteine N-acetylcysteine, and glutathione. Chem. Res. Toxicol. 1998, 11:909-916.
7. Cavalieri E.L., Devanesan P., Bosland M.C., Badawi A.F., Rogan E.G. Catechol estrogen metabolites and conjugates in different regions of the prostate of noble rats treated with 4-hydroxyestradiol: Implications for estrogen-induced initiation of prostate cancer. Carcinogenesis 2002, 23:329-333.
8. Cavalieri E.L. Estrogens as endogenous genotoxic agents-DNA adducts and mutations. J. Natl. Cancer Inst. Monogr. 2000, 27:75-93.
9. Cavalieri E.L., Stack D.E., Devanesan P.D., Todorovic R., Dwivedy I., Higginbotham S., Johansson S.L., Patil K.D., Gross M.L., Gooden J.K., Ramanathan R., Cerny R.L., Rogan E.G. Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:10937-10942.
10. Colditz G.A. Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer. J. Natl. Cancer Inst. 1998, 90:814-823.
11. Convert O., Van Aerden C., Debrauwer L., Rathahao E., Molines H., Fournier F., Tabet J.C., Paris A. Reactions of estradiol-2,3-quinone with deoxyribonucleosides: possible insights in the reactivity of estrogen quinones with DNA. Chem. Res. Toxicol. 2002, 15:754-764.
12. Department of Health Executive Yuan, Republic of China (Taiwan) Health and Vital Statistics: I. General Health Statistics. Taipei 2006.
13. Feigelson H.S., Henderson B.E. Estrogens and breast cancer. Carcinogenesis 1996, 17(11):2279-2284.
14. Funk W.E., Waidyanatha S., Chaing S.H., Rappaport S.M. Hemoglobin adducts of benzene oxide in neonatal and adult dried blood spots. Cancer Epidemiol. Biomarkers Prev. 2008, 17(8):1896-1901.
15. Han X., Liehr J.G. DNA single-strand breaks in kidneys of syrian hamsters treated with steroidal estrogens: hormone-induced free radical damage preceding renal malignancy. Carcinogenesis 1994, 15:997-1000.
16. Hayes C.L., Spink D.C., Spink B.C., Cao J.Q., Walker N.J., Sutter T.R. 17 beta-Estradiol hydroxylation catalyzed by human cytochrome P450 1B1. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:9776-9781.
17. Hiraku Y., Yamashita N., Nishiguchi M., Kawanishi S. Catechol estrogens induce oxidative DNA damage and estradiol enhances cell proliferation. Int. J. Cancer 2001, 92:333-337.
18. Jankowiak R., Zamzow D., Stack D.E., Todorovic R., Cavalieri E.L., Small G.J. Spectral characterization of fluorescently labeled catechol estrogen 3,4-quinone-derived N7 guanine adducts and their identification in rat mammary gland tissue. Chem. Res. Toxicol. 1998, 11:1339-1345.
19. Lavigne J.A., Goodman J.E., Fonong T., Odwin S., He P., Roberts D.W., Yager J.D. The effects of catechol-O-methyltransferase inhibition on estrogen metabolite and oxidative DNA damage levels in estradiol-treated MCF-7 cells. Cancer Res. 2001, 61:7488-7494.
20. Lin P.H., Chen D.R., Wang T.W., Lin C.H., Chuang M.C. Investigation of the cumulative tissue doses of naphthoquinones in human serum using protein adducts as biomarker of exposure. Chem. Biol. Interact. 2009, 181(1):107-114.
21. Lin P.H., Lin C.H., Huang C.C., Fang J.P., Chuang M.C. 2,3,7,8-Tetrachlorodibenzo-p-dioxin modulates the induction of DNA strand breaks and poly(ADP-ribose) polymerase-1 activation by 17β-estradiol in human breast carcinoma cells through alteration of CYP1A1 and CYP1B1 expression. Chem. Res. Toxicol. 2008, 21:1337-1347.
22. Lin P.H., Nakamura J., Yamaghuji S., Asakura S., Swenberg J.A. Aldehydic DNA lesions induced by catechol estrogen in calf thymus DNA. Carcinogenesis 2003, 24:1133-1141.
23. Lu F., Zahid M., Saeed M., Cavalieri E.L., Rogan E.G. Estrogen metabolism and formation of estrogen-DNA adducts in estradiol-treated MCF-10F cells: the effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin induction and catechol-O-methyltransferase inhibition. J. Steroid Biochem. Mol. Biol. 2007, 105:150-158.
24. Mailander P.C., Meza J.L., Higginbotham S., Chakravarti D. Induction of A.T to G.C mutations by erroneous repair of depurinated DNA following estrogen treatment of the mammary gland of ACI rats. J. Steroid Biochem. Mol. Biol. 2006, 101:204-215.
25. Martucci C.P., Fishman J. P450 enzymes of estrogen metabolism. Pharmacol. Ther. 1993, 57:237-257.
26. Okobia M.N., Bunker C.H., Garte S.J., Zmuda J.M., Ezeome E.R., Anyanwu S.N., Uche E.E., Osime U., Ojukwu J., Kuller L.H., Ferrell R.E., Taioli E. Cytochrome P450 1B1 Val432Leu polymorphism and breast cancer risk in Nigerian women: a case control study. Infect. Agent Cancer 2009, 4(Suppl. 1):S12.
27. Parl F.F., Dawling S., Roodi N., Crooke P.S. Estrogen metabolism and breast cancer: a risk model. Ann. N.Y. Acad. Sci. 2009, 1155:68-75.
28. Rogan E.G., Badawi A.F., Devanesan P.D., Meza J.L., Edney J.A., West W.W., Higginbotham S.M., Cavalieri E.L. Relative imbalances in estrogen metabolism and conjugation in breast tissue of women with carcinoma: potential biomarkers of susceptibility to cancer. Carcinogenesis 2003, 24(4):697-702.
29. Sanderson J.T., Slobbe L., Lansbergen G.W., Safe S., van den Berg M. 2,3,7,8-Tetrachlorodibenzo-p-dioxin and diindolylmethanes differentially induce cytochrome P450 1A1, 1B1, and 19 in H295R human adrenocortical carcinoma cells. Toxicol. Sci. 2001, 61:40-48.
30. Shin A., Kang D., Choi J.Y., Lee K.M., Park S.K., Noh D.Y., Ahn S.H., Yoo K.Y. Cytochrome P450 1A1 (CYP1A1) polymorphisms and breast cancer risk in Korean women. Exp. Mol. Med. 2007, 39(3):361-366.
31. Spink D.C., Spink B.C., Cao J.Q., Gierthy J.F., Hayes C.L., Li Y., Sutter T.R. Induction of cytochrome P450 1B1 and catechol estrogen metabolism in ACHN human renal adenocarcinoma cells. J. Steroid Biochem. Mol. Biol. 1997, 62:223-232.
32. Waidyanatha S., Troester M.A., Lindstrom A.B., Rappaport S.M. Measurement of hemoglobin and albumin adducts of naphthalene-1,2-oxide, 1,2-naphthoquinone and 1,4-naptthoquinone after administration of naphthalene to F44 rats. Chem. Biol. Interact. 2002, 141(3):189-210.
33. Wang S.L., Chang Y.C., Chao H.R., Li C.M., Li L.A., Lin L.Y., Päpke O. Body burdens of polychlorinated dibenzo-p-dioxins, dibenzofurans, and biphenyls and their relations to estrogen metabolism in pregnant women. Environ. Health Perspect. 2006, 114(5):740-745.
34. Warner M., Eskenazi B., Mocarelli P., Gerthoux P.M., Samuels S., Needham L., Patterson D., Brambilla P. Serum dioxin concentrations and breast cancer risk in the seveso women's health study. Environ. Health Perspect. 2002, 110:625-628.
35. Yager J.D., Davidson N.E. Estrogen carcinogenesis in breast cancer. N. Engl. J. Med. 2006, 354:270-282.
36. Yager J.D. Endogenous estrogens as carcinogens through metabolic activation. J. Natl. Cancer Inst. Monogr. 2000, 27:67-73.
37. Yared E., McMillan T.J., Martin F.L. Genotoxic effects of oestrogens in breast cells detected by the micronucleus assay and the comet assay. Mutagenesis 2002, 17:345-352.
38. Zahid M., Kohli E., Saeed M., Rogan E.G., Cavalieri E.L. The greater reactivity of estradiol-3,4-quinone vs estradiol-2,3-quinone with DNA in the formation of depurinating adducts: implications for tumor-initiating activity. Chem. Res. Toxicol. 2006, 19:164-172.